Corporate & Securities

From Inception to Exit: Corporate Solutions for Every Stage of the Business Life Cycle

Stradling’s corporate and securities lawyers work at the center of many of the West Coast’s most significant transactions. Public and private companies – from today’s leading brands to tomorrow’s household names – rely on our long track record and deep bench of lawyers to get their deals done right.

For start-ups to established public companies, we offer solutions for every stage of the business lifecycle. Our team is ready to tackle the next steps that bring our clients closer to achieving their business goals, whether through new company formation, private equity, venture capital or debt financings, mergers, acquisitions or initial public offerings. While our deal volume and experience rival large firms, our commitment to providing attentive and fairly priced services has helped us grow decades-long relationships with clients along the West Coast and across the country.

Growth Strategies for the West Coast and Beyond

Medical device, pharmaceutical, software, IT, retail and consumer products companies trust our counsel in the transactions that fuel growth and innovation. Our team helps young companies with new and novel technologies or highly sought-after products. We also represent established businesses and investors seeking to acquire emerging companies as part of their private equity or growth initiatives.

Representing Public Companies

Public company boards of directors rely on our counsel to address their most critical business issues. Our leadership and knowledge have facilitated numerous multi-million and multi-billion-dollar debt and equity financings, strategic alliances, mergers and acquisitions and corporate securities offerings. We get deals done quickly and efficiently with thorough due diligence and sound deal structures that avoid litigation exposure.

Keeping Start-ups on a Path to Success

Without the right resources and advice, entrepreneurs and executives juggling the demands of a fast-paced start-up environment often lack a clear view of future challenges and roadblocks. By helping start-ups define and prioritize issues, we bring certainty to complex decisions. Due to our long-standing relationships with investors, we frequently connect start-ups to new sources of capital or potential buyers. Our widely-read blog (https://www.startupblog.com) is a comprehensive resource on today’s most pressing legal and compliance concerns, and proven best practices.

Proactive Corporate Counsel and Governance Solutions

The results we achieve in boardrooms and negotiation tables have earned the respect of boards of directors who count on our counsel for general corporate and governance matters. In high-stakes transactions, our market analysis and ability to communicate productively with all parties involved helps our clients plan for realistic outcomes. We also frequently advise companies on the key governance concerns affecting their future operations, including fiduciary duty, employee stock ownership, reorganization, licensing, distribution and securities compliance.

Representative examples of our corporate and securities matters include:

  • Representing Sunworks (NAS: SUNW), a photovoltaic-based power provider, in its acquisition by the Peck Company Holdings (NAS: PECK)
  • The $287.5 million private placement offering of 1.50% convertible senior notes by Tandem Diabetes Care (NAS:TNDM) — a San Diego-based insulin and glucose monitoring device company. Tandem entered into capped call transactions to reduce potential dilution to common stockholders on any conversion of the notes or offset any cash payments.
  • Deckers Brands (NYS: DECK) in its $400 Million credit financing with JP Morgan, as well as its acquistions of the Sanuk and Koolaburra brands.
  • The $86 million initial public offering of AppFolio, Inc. (NAS: APPF) — a Santa Barbara-based provider of cloud-based software solutions —  through an offering of 7,130,000 shares of its Class A common stock.
  • Gallant Capital in its acquisition of all of Aerostar Aerospace Manufacturing’s outstanding secured debt and equity, and in closing a control equity investment in Aero Turbine, Inc. Aero Turbine provides the U.S. Air Force and other customers with maintenance, repair and overhaul services for jet engines.
  • The $138 million initial public offering of Tandem Diabetes Care (NAS: TNDM)
  • inXile Entertainment Inc. — an Orange County-based role-playing video game developer —  in its acquisition by Microsoft Corp (NAS: MSFT) for an undisclosed sum. The acquisition will aid in Microsoft’s quest to become the “Netflix of video game streaming and original content.”
  • Restaurant365 — a cloud-based accounting software solution for restaurants —  in raising more than $120 million of financing through series A, B and C funding rounds from disclosed and undisclosed investors including Bessemer Venture Partners, ICONIQ Capital and Tiger Global Management. The funds will be used to accelerate growth and expanded the company's team.
  • Mechanix Wear, Inc. — a Valencia, CA-based leading designer and manufacturer of high performance work gloves —  in receiving a significant investment from Gryphon Investors, a San Francisco based middle-market private equity firm.
  • The Series D and D1 ($15.5 million, $8 million), Series E ($22.7 million), Series 2 ($5.97 million), and Series B ($28.78 million, $26.06 million) financings for Vertos Medical, a developer of minimally invasive medical devices that assist in the treatment of common spinal diseases.
  • Salas O'Brien Engineers in its acquisition of eight engineering firms across seven states since 2018.
  • Ansun Biopharma in its $85 million Series A financing in a deal led by Lilly Asia Ventures and Sinopharm Healthcare Fund.
  • National Freight Holdings, LLC —  a portfolio company of Gallant Capital Partners —  in two stock purchase agreements aimed to help the company expand its point to point logistics business. 
  • Anchore Inc. — a Santa Barbara-based container inspection and compliance solutions provider  —  in its $20 million Series A financing led by venture capital firm Signal Fire.
  • Endologix, a manufacturer of medical devices for the treatment of aortic disorders, in its $170 million credit facililty with Deerfield Management.